Treatment of nail psoriasis with adalimumab: an open label unblinded study.

@article{Rigopoulos2010TreatmentON,
  title={Treatment of nail psoriasis with adalimumab: an open label unblinded study.},
  author={Dimitris Rigopoulos and Stamatis Gregoriou and Elisabeth Lazaridou and Elena Belyayeva and Zoe Apalla and Manolis Makris and Andreas D Katsambas and Demetris Ioannides},
  journal={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2010},
  volume={24 5},
  pages={530-4}
}
BACKGROUND Despite numerous advances in the therapeutic management of cutaneous psoriasis, there is a lack of standardized therapeutic regimens for psoriatic nail disease. OBJECTIVE An open, non-randomized, unblinded study was designed to evaluate the efficacy and safety of adalimumab in the treatment of nail psoriasis. PATIENTS/METHODS Seven patients suffering from severe plaque-type psoriasis and 14 with psoriatic arthritis and cutaneous psoriasis with concomitant nail involvement were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Biologic and Systemic Agents in Dermatology

Springer International Publishing • 2018
View 10 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 18 references

Treatment options for nail psoriasis

S Gregoriou, D Kalogeromitros, N Kosionis, A Gkouvi, D. Rigopoulos
Exp Rev Dermatol • 2008

Similar Papers

Loading similar papers…